At LSC we specialise only in Life Sciences and always keep up to date with leading news, projects and all that’s going on in the industry. As the sector sees continued rapid growth it’s easy to miss some of the major announcements. To make things easier and to ensure you too are well informed we’ve selected and summarized this month’s top Irish Life Science industry news stories below.
WuXi Biologics to Invest €325 million to Build Largest Biomanufacturing Facility Using Single-use Bioreactors in Ireland
WuXi Biologics, a Hong Kong-listed global open-access biologics technology platform company, is to develop a new biologics drug substance manufacturing facility on the IDA’s greenfield site in Dundalk, Co. Louth. The €325 million investment is set to create up to 400 jobs and will be company’s first site outside of China. The facility will be built by deploying multiple single-use bioreactors for commercial biomanufacturing and will be the world’s largest facility using single-use bioreactors. Read the full article here.
PCI launch new High Containment Packaging Facility in Drogheda and announce 100 new jobs
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) have launched a new contained packaging facility in Co. Louth. The new facility, set up in Drogheda, specialises in the primary and secondary packaging of highly potent products. It will lead to the creation of more than 70 jobs over the next five years in Drogheda while 50 new jobs will be created at it’s Meath facility. CEO of IDA Martin Shanahan welcomed the news saying “The availability of this range of clinical and pharmaceutical services will increase the attractiveness of Ireland as an international base for early stage speciality Biopharma companies”. Read the full article here.
Dublin-headquartered pharma firm Shire to sell its oncology business for $2.4bn
Rare diseases specialist, Shire, is selling its oncology business to French drugmaker Servier for $2.4 billion. The firm, which has it’s headquarters in Dublin, started looking at offloading the oncology business in December having concluded it was no longer core to Shire’s long term strategy. The process considered “multiple potential strategic buyers” across Europe, Japan and the US. The deal with Servier is expected to close in the second or third quarter of this year. Read the full article here.
Finesse Medical to create 200 jobs in Longford as part of expansion
200 jobs are to be created by a US-owned medical supplies company based in Co.Longford over the next four years. Finesse Medical was set up in 2004 and produces products for wound care and skin treatment, including skin barrier films and protection creams, and silicone and polyurethane foam wound dressings. The announcement is linked to the firm’s multi-million euro takeover last year by New York-listed Avery Dennison Corporation. Avery Dennison said on Thursday that construction on a 6,000 square meter facility expansion that will include a new clean room, integrated converting and manufacturing capabilities, will commence in September. Read the full article here.